Table 1.
Clinical and biochemical characteristics of the 961 participants
| Mean ± SD | Median (Q1-Q3) | |
|---|---|---|
| Age (y) |
49 ± 14 |
50 (38–60) |
| Body weight (kg) |
73.6 ± 15.9 |
72.0 (61.6 - 83.5 |
| BMI (kg/m2) |
27.9 ± 5.4 |
27.2 (24.1-31.0) |
| Circumferences |
|
|
| Waist (cm) |
94.3 ± 14.5 |
94.0 (85.0 - 103.0) |
| Hip (cm) |
104.6 ± 12.3 |
104.0 (98.0 - 110.0) |
| Systolic BP (mmHg) |
129 ± 16 |
128 (118–139) |
| Diastolic BP (mmHg) |
79 ± 10 |
78 (72–85) |
| Heart rate (beats/min) |
74 ± 11 |
73 (66–81) |
| Random capillary blood glucose (mg/dl) |
91 ± 12 |
90 (82–97) |
| Blood concentration of |
n = 507 |
|
| glycated hemoglobin% |
5.6 ± 0.4 |
5.5 (5.3 - 5.8) |
| mmol/mol |
37.4 ± 4.8 |
36.6 (34.4 - 39.9) |
| glucose (mg/dl) |
88 ± 21 |
85 (75–97) |
| total cholesterol (mg/dl) |
213 ± 39 |
212 (185–240) |
| hdl cholesterol (mg/dl) |
59 ± 15 |
58 (49–67) |
| triglycerides (mg/dl) |
101 ± 49 |
90 (68–121) |
| ldl cholesterol (mg/dl) |
133 ± 36 |
131 (108–161) |
| uric acid (mg/dl) |
5.0 ± 1.4 |
4.7 (3.9 - 5.9) |
| insulin (μu/ml) |
9.6 ± 5.8 |
8.2 (5.6 - 11.8) |
| HOMA-IR |
2.2 ± 1.5 |
1.8 (1.2 - 2.7) |
| HOMA-β |
141.8 ± 104.5 |
117.9 (80.0 - 171.4) |
| Creatinine (mg/dL) |
0.83 ± 0.21 |
0.79 (0.69 - 0.94) |
| eGFR-MDRD (mL/min/1.73 m2) | 91.8 ± 20.3 | 90.3 (76.5 – 94.4) |
BMI: body mass index; BP: blood pressure; eGFR: estimated glomerular filtration rate; HDL: high-density lipoproteins; HOMA-IR: homeostasis model assessment of insulin resistance; HOMA-β: homeostasis model assessment of β-cell function; LDL: low-density lipoproteins; MDRD: modification of diet in renal disease study.